Foralumab
Foralumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Foralumab is under investigation in clinical trial NCT03291249 (Assessment of the Safety of Foralumab, an Oral Anti-cd3 Antibody, in Patients With NASH and T2DM).
| Trade Name | Foralumab |
| Generic | Foralumab |
| Foralumab Other Names | Foralumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Foralumab
